✦ LIBER ✦

T01-P-025 Rosiglitazone lowers apolipoprotein A1 and apolipoprotein B levels and increases LDL/APOB ratio in patients with type 2 diabetes and hypertension

✍ Scribed by Sarafidis, P.; Lasaridis, A.; Yovos, J.; Mousleh, T.; Kazakos, K.; Makedou-HitogIou, A.; Pliakos, C.; Stafilas, P.; Tourkantonis, A.; Nilsson, P.

Book ID: 118633623
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 145 KB
Volume: 6
Category: Article
ISSN: 1567-5688
DOI: 10.1016/s1567-5688(05)80542-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

T01-P-024 The effect of rosiglitazone on

T01-P-024 The effect of rosiglitazone on fibrinogen levels and platelet count in patients with type 2 diabetes and hypertension

✍ Sarafidis, P.; Lasaridis, A.; Yovost, J.; Mousleh, Z.; Kazakos, A.; Makedou-Kour 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 145 KB